InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EXS | copperchem | 17/12/17 | 4 | 741 | |||
|
|||||||
EXS | Ann: Removal from Official Quotation (cob 15/01/1 | 14/01/13 | 0 | 646 | |||
|
|||||||
EXS +SOL | Ann: Completion of compulsory acquisition | 28/12/12 | 0 | 832 | |||
|
|||||||
EXS | any court challenges to mandatory acquisition? | 07/12/12 | 0 | 435 | |||
|
|||||||
EXS | Ann: Suspension from Official Quotation cob 5/12/ | 04/12/12 | 0 | 572 | |||
|
|||||||
EXS +IVA | Ann: Ceasing to be a substantial holder from IVA | 03/12/12 | 0 | 613 | |||
|
|||||||
EXS | Ann: Final Director's Interest Notice x 5 | 30/11/12 | 0 | 509 | |||
|
|||||||
EXS | Ann: Results of Annual General Meeting 2012 | 30/11/12 | 0 | 313 | |||
|
See All Discussions